Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Neuropsychopharmacology (2)
Scientific Reports (2)
Nature (1)
Nature Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (4)
Amendments and Corrections (1)
News & Views (1)

Subject Check one or more subjects to show results from those subjects only.

Anatomy
Biochemistry
Cell biology
Computational biology and bioinformatics
Drug discovery
Health care
Neurology
Neuroscience
Structural biology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–6 of 6 results

Advanced filters: Author: Iain R. Greig Clear advanced filters

Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors

Aymen I Idris
Robert J van 't Hof
Stuart H Ralston
Research22 May 2005
Nature Medicine

Volume: 11, P: 774-779
Designer cannabinoids could be the key to pain relief without adverse effects

Current approaches to pain relief are falling short. Chemically modifying a synthetic cannabinoid could enable scientists to capitalize on the body’s natural pain-killing pathway without evoking drug tolerance or psychoactivity.

Iain R. Greig
Ruth A. Ross
News & Views05 Mar 2025
Nature

Volume: 640, P: 45-46
A novel allosteric modulator of the cannabinoid CB₁ receptor ameliorates hyperdopaminergia endophenotypes in rodent models

Catharine A. Mielnik
Kim S. Sugamori
Ruth A. Ross
ResearchOpen Access08 Oct 2020
Neuropsychopharmacology

Volume: 46, P: 413-422
AI is a viable alternative to high throughput screening: a 318-target study

Izhar Wallach
Denzil Bernard
Abraham Heifets
ResearchOpen Access02 Apr 2024
Scientific Reports

Volume: 14, P: 1-16
A Cannabinoid CB₁ Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects

Bogna M Ignatowska-Jankowska
Gemma L Baillie
Ruth A Ross
Research08 Jun 2015
Neuropsychopharmacology

Volume: 40, P: 2948-2959
Author Correction: AI is a viable alternative to high throughput screening: a 318-target study

Izhar Wallach
Denzil Bernard
Ellie Giles
Amendments and CorrectionsOpen Access16 Sept 2024
Scientific Reports

Volume: 14, P: 1-2